{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:42:17Z","timestamp":1785454937865,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP19110"],"award-info":[{"award-number":["GGP19110"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ceca.2022.102605","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:16:04Z","timestamp":1652872564000},"page":"102605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-7600","authenticated-orcid":false,"given":"Beatrice","family":"Riva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-7288","authenticated-orcid":false,"given":"Emanuela","family":"Pessolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Cordero-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene P.","family":"Bhela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Topf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-8359","authenticated-orcid":false,"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-6267","authenticated-orcid":false,"given":"Daniel","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-2886","authenticated-orcid":false,"given":"Matteo","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7351-959X","authenticated-orcid":false,"given":"Rita","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-4787","authenticated-orcid":false,"given":"Tracey","family":"Pirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1923-7430","authenticated-orcid":false,"given":"Armando A.","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceca.2022.102605_bib0001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12938","article-title":"Diseases caused by mutations in ORAI1 and STIM1","volume":"1356","author":"Lacruz","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ceca.2022.102605_bib0002","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jmedgenet-2014-102623","article-title":"Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1","volume":"51","author":"B\u00f6hm","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ceca.2022.102605_bib0003","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1073\/pnas.1312520111","article-title":"Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis","volume":"111","author":"Nesin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2022.102605_bib0004","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/hmg\/ddu477","article-title":"Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca(2)(+) channels","volume":"24","author":"Endo","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ceca.2022.102605_bib0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1055\/s-0038-1649920","article-title":"Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality?","volume":"74","author":"Stormorken","year":"1995","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ceca.2022.102605_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.522513","article-title":"Stormorken syndrome caused by a novel STIM1 mutation: a case report","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.ceca.2022.102605_bib0007","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ymgme.2014.12.307","article-title":"York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1","volume":"114","author":"Markello","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ceca.2022.102605_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0143-4160(86)90026-6","article-title":"A model for receptor-regulated calcium entry","volume":"7","author":"Putney","year":"1986","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2022.102605_bib0009","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00020.2014","article-title":"Store-operated calcium channels","volume":"95","author":"Prakriya","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ceca.2022.102605_bib0010","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/humu.23338","article-title":"Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy","volume":"38","author":"Barone","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ceca.2022.102605_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00401-017-1775-x","article-title":"CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy","volume":"135","author":"B\u00f6hm","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ceca.2022.102605_bib0012","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/humu.23172","article-title":"ORAI1 mutations with distinct channel gating defects in tubular aggregate nyopathy","volume":"38","author":"B\u00f6hm","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ceca.2022.102605_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/humu.23899","article-title":"Tubular aggregate myopathy and stormorken syndrome: mutation spectrum and genotype\/phenotype correlation","volume":"41","author":"Morin","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ceca.2022.102605_bib0014","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/mus.27391","article-title":"Expanding the clinical and genetic spectrum of pathogenic variants in STIM1","volume":"64","author":"Ticci","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ceca.2022.102605_bib0015","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1016\/j.nmd.2015.06.369","article-title":"A novel STIM1 mutation at p.340 causes tubular aggregate myopathy with miosis without additional features of Stormorken syndrome","volume":"25","author":"Harris","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ceca.2022.102605_bib0016","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41467-018-03062-w","article-title":"A dual mechanism promotes switching of the Stormorken STIM1 R304W mutant into the activated state","volume":"9","author":"Fahrner","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ceca.2022.102605_bib0017","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/humu.22621","article-title":"Gain-of-function mutation in STIM1 (p.R304W) Is associated with stormorken syndrome","volume":"35","author":"Morin","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ceca.2022.102605_bib0018","unstructured":"Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase. Identifier: NCT04195347. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04195347. Last update November 1, 2021. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0019","unstructured":"CM4620 injectable emulsion versus supportive care in patients with acute pancreatitis and SIRS. Identifier: NCT03401190. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03401190. Last update: December 7, 2021. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0020","unstructured":"A PK\/PD Study of CM4620-IE in Patients With Acute Pancreatitis. Identifier: NCT03709342. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03709342. Last update: September 19, 2019. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0021","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MPA.0000000000001793","article-title":"Auxora for the treatment of patients with acute pancreatitis and accompanying systemic inflammatory response syndrome","volume":"50","author":"Bruen","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.ceca.2022.102605_bib0022","unstructured":"A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS (CARPO). Identifier: NCT04681066. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04681066. Last update December 17, 2021. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0023","unstructured":"A Study of Auxora in Patients With Severe COVID-19 Pneumonia. Identifier: NCT04345614. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04345614. Last update : August 3, 2021. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0024","unstructured":"A Study of Auxora in Patients With Critical COVID-19 Pneumonia. Identifier : NCT04661540. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04661540. Last update : August 2, 2021. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s13054-020-03220-x","article-title":"Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial","volume":"24","author":"Miller","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.ceca.2022.102605_bib0026","unstructured":"Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals. Identifier: NCT02958982. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02958982. Last update: October 4, 2019. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0027","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jcpt.13322","article-title":"A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers","volume":"46","author":"Barde","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ceca.2022.102605_bib0028","unstructured":"A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis. Identifier: NCT03614078. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03614078. Last update: March 30, 2020. (Accessed December 20, 2021)."},{"key":"10.1016\/j.ceca.2022.102605_bib0029","series-title":"Patients With Relapsed or Refractory Lymphomas. Identifier: NCT03119467","article-title":"Safety and Efficacy Study of RP4010","year":"2019"},{"key":"10.1016\/j.ceca.2022.102605_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653812","article-title":"ORAI1 Ca2+ channel as a therapeutic target in pathological vascular remodelling","volume":"9","author":"Shawer","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.ceca.2022.102605_bib0031","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/JP277079","article-title":"ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain","volume":"597","author":"Bulla","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.ceca.2022.102605_bib0032","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3390\/cancers12102876","article-title":"Blockage of store-operated Ca2+ influx by synta66 is mediated by direct inhibition of the Ca2+ selective orai1 pore","volume":"12","author":"Waldherr","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ceca.2022.102605_bib0033","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1021\/acs.jmedchem.1c01403","volume":"64","author":"Khedkar","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ceca.2022.102605_bib0034","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00424-016-1880-z","article-title":"Molecular mechanisms underlying inhibition of STIM1-Orai1-mediated Ca2+ entry induced by 2-aminoethoxydiphenyl borate","volume":"468","author":"Wei","year":"2016","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ceca.2022.102605_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ceca.2012.11.005","article-title":"The action of selective CRAC channel blockers is affected by the Orai pore geometry","volume":"53","author":"Derler","year":"2013","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2022.102605_bib0036","doi-asserted-by":"crossref","first-page":"13186","DOI":"10.1073\/pnas.1300910110","article-title":"Ca2+ release-activated Ca2+ channel blockade as a potential tool in antipancreatitis therapy","volume":"110","author":"Gerasimenko","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2022.102605_bib0037","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1476-5381.2012.02126.x","article-title":"Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways","volume":"167","author":"Schleifer","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ceca.2022.102605_bib0038","doi-asserted-by":"crossref","first-page":"9756","DOI":"10.1021\/acs.jmedchem.8b01512","article-title":"Pyrtriazoles, a novel class of store-operated calcium entry modulators: discovery, biological profiling, and in vivo proof-of-concept efficacy in acute pancreatitis","volume":"61","author":"Riva","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ceca.2022.102605_bib0039","doi-asserted-by":"crossref","first-page":"31348","DOI":"10.1074\/jbc.M804942200","article-title":"Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels","volume":"283","author":"Ng","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2022.102605_bib0040","doi-asserted-by":"crossref","first-page":"14761","DOI":"10.1021\/acs.jmedchem.0c01305","article-title":"Store-operated calcium entry (SOCE) as a therapeutic target in acute pancreatitis: discovery and development of drug-like SOCE inhibitor","volume":"63","author":"Serafini","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ceca.2022.102605_bib0041","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/cge.12888","article-title":"A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis","volume":"91","author":"Garibaldi","year":"2016","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ceca.2022.102605_bib0042","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.041111","article-title":"A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy","volume":"3","author":"Cordero-Sanchez","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ceca.2022.102605_bib0043","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2022.102605_bib0044","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.nmd.2017.05.002","article-title":"Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains","volume":"9","author":"Harris","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ceca.2022.102605_bib0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/humu.23172","article-title":"ORAI1 mutations with distinct channel gating defects in tubular aggregate myopathy","volume":"38","author":"B\u00f6hm","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ceca.2022.102605_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.604941","article-title":"STIM1\/ORAI1 loss-of-function and gain-of-function mutations inversely impact on SOCE and calcium homeostasis and cause multi-systemic mirror diseases","volume":"11","author":"Silva-Rojas","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ceca.2022.102605_bib0047","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/hmg\/ddy446","article-title":"STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice","volume":"28","author":"Silva-Rojas","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ceca.2022.102605_bib0048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ceca.2018.10.001","article-title":"STIM1 R304W causes muscle degeneration and impaired platelet activation in mice","volume":"76","author":"Gamage","year":"2018","journal-title":"Cell Calcium"}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416022000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416022000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:31:10Z","timestamp":1758918670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416022000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":48,"alternative-id":["S0143416022000793"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2022.102605","relation":{},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2022.102605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102605"}}